Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
about
Genetic heterogeneity in Alzheimer disease and implications for treatment strategiesBiochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseAPOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease.The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.Approach to atypical Alzheimer's disease and case studies of the major subtypes.Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease.Different Hippocampus Functional Connectivity Patterns in Healthy Young Adults with Mutations of APP/Presenilin-1/2 and APOEε4.Modulation of glucose metabolism and metabolic connectivity by β-amyloid.Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype.Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study
P2860
Q26995802-1B16452B-F1EF-495E-A5EC-68924505D0BDQ28542628-2C011E19-5FEA-494C-A01C-A3ECAFA2515DQ34622674-E1167F22-DC85-454C-A78C-1CAA49749B07Q35905536-10E17DD9-43D7-40F5-9F03-7D73011D6B0DQ36217479-D4FE09AE-3FC2-41D6-A79B-C7D3961E7AB4Q36408912-1B8BBBC0-7344-4393-A6FF-86219FF4B34BQ36873936-5A0E458F-51C1-4087-B596-78F82A522729Q37220632-1E5C51D5-EB37-41AD-A9CD-9C576E835003Q38400509-CCECD2EB-FFAB-4AD3-938A-FD2AEC431E95Q39135327-84810B3A-2C49-44C5-BFC7-76C261E83E59Q40649206-AA6A52A6-EA0B-415E-9314-12FA3A508C96Q47234924-6F095009-35DD-4069-8DFC-977016250AB1Q48147971-B72F0D10-F916-4B84-92C9-68193DF583B7Q51703164-EB38A08B-E4DB-4DD2-B0AF-9393AE1B3D16Q51766183-D41FD03D-0B57-45AE-B0FE-03FC9F399014Q53397288-790E85F6-0547-444B-AC6A-E47576C570A7Q58797598-D697C36F-C1B9-4165-AF48-16029EECDE3F
P2860
Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Greater medial temporal hypome ...... in ApoE4-positive AD patients.
@en
Greater medial temporal hypome ...... in ApoE4-positive AD patients.
@nl
type
label
Greater medial temporal hypome ...... in ApoE4-positive AD patients.
@en
Greater medial temporal hypome ...... in ApoE4-positive AD patients.
@nl
prefLabel
Greater medial temporal hypome ...... in ApoE4-positive AD patients.
@en
Greater medial temporal hypome ...... in ApoE4-positive AD patients.
@nl
P2093
P2860
P356
P1476
Greater medial temporal hypome ...... in ApoE4-positive AD patients.
@en
P2093
Anna Karydas
Cindee Madison
Giovanni Coppola
James P O'Neil
Manja Lehmann
Pia M Ghosh
William J Jagust
Yadong Huang
P2860
P304
P356
10.1136/JNNP-2013-305858
P407
P577
2013-08-21T00:00:00Z